Skip to main content

Table 3 Characteristics of patients developing/ not developing AKI at entry into study

From: Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study

 

AKI event during follow-up

No AKI event during follow-up

(n = 4944)

(n = 20,204)

Age (Years) a

71.7 (64.7 – 78.3)

63.4 (54.2 – 72.1)

Male Sex (%)

2694 (54.5)

11,031 (54.6)

HbA1c %

7.2 (6.4- 8.3)

7.0 (7.4- 8.4)

(mmol/mol) a

55 (46 – 67)

53 (45 - 68)

Diabetes Duration (years) a

0 (0 – 3)

3.3 (0 – 9)

Number of diabetes drug classes (%)

0

2583 (52)

14,212 (70)

1

1617 (33)

4471 (22)

2

706 (14)

1438 (7)

3

27 (0.5)

76 (0.4)

4

1

6

5

0

1

ACE/ARB use (%)

1505 (30)

4667 (23)

NSAID use (%)

474 (10)

2079 (10)

  1. aMedian & IQR